Home    Back

96. Crohn disease
2,209 clinical trials,   1,276 drugs   (DrugBank: 240 drugs),   166 drug target genes,   210 drug target pathways

Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
9 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2010-020881-53-ES
(EUCTR)		25/05/201101/12/2010Una evaluación a largo plazo de la seguridad y la eficacia del tratamiento con AMG 827 en sujetos con enfermedad de Crohn. /A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease.Una evaluación a largo plazo de la seguridad y la eficacia del tratamiento con AMG 827 en sujetos con enfermedad de Crohn. /A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease. Crohn's disease / Enfermedad de Crohn
MedDRA version: 12.1;Level: LLT;Classification code 10013099;Term: Disease Crohns		Product Name: AMG 827
Product Code: AMG 827
INN or Proposed INN: AMG 827		Amgen IncNULLNot RecruitingFemale: yes
Male: yes		195Netherlands;Belgium;Spain
2EUCTR2010-020881-53-NL
(EUCTR)		04/04/201117/12/2010A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn’s DiseaseA Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn’s Disease Crohns Disease
MedDRA version: 12.1;Level: LLT;Classification code 10013099;Term: Disease Crohns		Product Name: AMG 827
Product Code: AMG 827
INN or Proposed INN: AMG 827		Amgen IncNULLNot RecruitingFemale: yes
Male: yes		195Netherlands;Belgium;Spain
3EUCTR2010-020881-53-BE
(EUCTR)		18/01/201124/11/2010Safety Study in Subjects With Crohn's DiseaseA Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn’s Disease Crohn's Disease
MedDRA version: 14.0;Level: LLT;Classification code 10013099;Term: Disease Crohns;System Organ Class: 10017947 - Gastrointestinal disorders;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]		Product Name: AMG 827
Product Code: AMG 827
INN or Proposed INN: AMG 827		Amgen IncNULLNot RecruitingFemale: yes
Male: yes		195Phase 2France;United States;Canada;Spain;Poland;Belgium;Australia;Netherlands
4EUCTR2010-019544-39-NL
(EUCTR)		06/01/201130/08/2010A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects with Moderate to Severe Crohn’s DiseaseA Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects with Moderate to Severe Crohn’s Disease Crohn’s disease
MedDRA version: 12.1;Level: LLT;Classification code 10011408;Term: Crohns disease aggravated		Product Name: AMG 827
Product Code: AMG 827		Amgen IncNULLNot RecruitingFemale: yes
Male: yes		216Netherlands;Belgium;France;Spain
5NCT01199302
(ClinicalTrials.gov)		December 20109/9/2010Safety Study in Subjects With Crohn's DiseaseA Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's DiseaseCrohn's DiseaseDrug: AMG 827AmgenNULLTerminatedN/AN/ABoth67Phase 2United States;Australia;Belgium;Canada;France;Netherlands;Poland;Spain
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
6EUCTR2010-019544-39-ES
(EUCTR)		25/11/201003/09/2010Estudio aleatorizado, a doble ciego, controlado con placebo para evaluar la seguridad, tolerabilidad y eficacia de AMG 827 en sujetos con enfermedad de Crohn de moderada a grave / A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects with Moderate to Severe Crohn's DiseaseEstudio aleatorizado, a doble ciego, controlado con placebo para evaluar la seguridad, tolerabilidad y eficacia de AMG 827 en sujetos con enfermedad de Crohn de moderada a grave / A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects with Moderate to Severe Crohn's Disease Crohn's disease / Enfermedad de Crohn
MedDRA version: 12.1;Level: LLT;Classification code 10011408;Term: Crohns disease aggravated		Product Name: AMG 827
Product Code: AMG 827		Amgen IncNULLNot RecruitingFemale: yes
Male: yes		216Netherlands;Belgium;France;Spain
7EUCTR2010-019544-39-BE
(EUCTR)		04/10/201017/08/2010AMG 827 in Subjects With Moderate to Severe Crohn's DiseaseA Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects with Moderate to Severe Crohn’s Disease Crohn’s disease
MedDRA version: 14.0;Level: LLT;Classification code 10011408;Term: Crohns disease aggravated;System Organ Class: 10017947 - Gastrointestinal disorders;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]		Product Name: AMG 827
Product Code: AMG 827
INN or Proposed INN: AMG 827		Amgen IncNULLNot RecruitingFemale: yes
Male: yes		216Phase 2France;United States;Canada;Spain;Poland;Belgium;Australia;Netherlands
8EUCTR2010-019544-39-FR
(EUCTR)		04/10/201006/09/2010A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects with Moderate to Severe Crohn’s DiseaseA Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects with Moderate to Severe Crohn’s Disease Crohn’s disease
MedDRA version: 12.1;Level: LLT;Classification code 10011408;Term: Crohns disease aggravated		Product Name: AMG 827
Product Code: AMG 827		Amgen IncNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes		216Netherlands;Belgium;France;Spain
9NCT01150890
(ClinicalTrials.gov)		July 201024/6/2010AMG 827 in Subjects With Moderate to Severe Crohn's DiseaseA Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's DiseaseCrohn's DiseaseDrug: AMG 827 350 MG;Drug: AMG 827 210 MG;Drug: AMG 827 700 MG;Drug: PlaceboAmgenNULLTerminated18 Years65 YearsBoth130Phase 2United States;Australia;Belgium;Canada;France;Netherlands;Poland;Spain

Back to top